GlassScriptPhysician profile
Stephen B Kornfeld
NPI 1164533667
$2,629.70
in general payments reported to CMS, 2019-2025
18 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $744 · 2020: $99.58 · 2021: $13.86 · 2022: $530 · 2023: $689 · 2024: $326 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,241.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $767.95 | 2019-2024 | Opdivo |
| Astrazeneca Pharmaceuticals LP | $260.00 | 2022-2023 | Tagrisso |
| Genentech USA, INC. | $234.39 | 2022-2023 | Lunsumio |
| Abbvie INC. | $201.18 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $125.00 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $123.90 | 2022 | |
| Beone Medicines USA, INC. | $111.12 | 2025 | Brukinsa |
| Novartis Pharmaceuticals Corporation | $110.00 | 2019 | |
| Rigel Pharmaceuticals, INC. | $109.99 | 2019 | |
| Emd Serono, INC. | $107.52 | 2023 | Bavencio |
| Progenics Pharmaceuticals, INC. | $107.45 | 2023 | Pylarify |
| Daiichi Sankyo INC. | $105.40 | 2024 | Enhertu |
| Beigene USA, INC. | $104.25 | 2023 | Brukinsa |
| Incyte Corporation | $84.90 | 2023 | Jakafi |
| Genmab U.S., INC. | $38.75 | 2024 | Epkinly |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.86 | 2021 | |
| Puma Biotechnology, INC. | $13.12 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $10.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kornfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.